Drug Database
Back to search

Canada· CA-DIN-02434970

OCTAPLEX

A coagulation factor ix, ii, vii and x in combination product containing coagulation factor ii (human) + protein s + protein c + coagulation factor vii (human), registered in Canada by OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedOCTAPLEXATCB02BD01REGISTER NO.CA-DIN-02434970PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about coagulation factor ii (human) + protein s + protein c + coagulation factor vii (human)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor ix, ii, vii and x in combination products by name

Coagulation factor ix, ii, vii and x in combination · ATC B02BD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
COAGULATION FACTOR II (HUMAN) + PROTEIN S + PROTEIN C + COAGULATION FACTOR VII (HUMAN)
Manufacturer
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
Country
Canada (CA)
ATC code
B02BD01
ATC class
Coagulation factor IX, II, VII and X in combination
Defined daily dose
1.6 TSD, E
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for coagulation factor ix, ii, vii and x in combination.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor ix, ii, vii and x in combination against other medicinesHow interaction checks work

Coagulation factor ix, ii, vii and x in combination · interactions on record

3 records

  • 2 severe
  • 1 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B02BD01

Coagulation factor ix, ii, vii and x in combination, as other registers publish it.

All coagulation factor ix, ii, vii and x in combination products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/12896e97-0a93-453c-8f28-6ff6fd8a1767
GET /v1/drugs/12896e97-0a93-453c-8f28-6ff6fd8a1767?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02434970",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B02BD01",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "91926",
  "strengths": [
    "1520 UNIT",
    "1280 UNIT",
    "1240 UNIT",
    "960 UNIT",
    "1000 UNIT",
    "1200 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "COAGULATION FACTOR II (HUMAN)",
    "PROTEIN S",
    "PROTEIN C",
    "COAGULATION FACTOR VII (HUMAN)",
    "COAGULATION FACTOR IX (HUMAN)",
    "COAGULATION FACTOR X (HUMAN)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about coagulation factor ix, ii, vii and x in combination.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console